Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The latest in multiple myeloma: a European and US perspective

Prof Paul Richardson and Prof Marivi Mateos
The latest in multiple myeloma: a European and US perspective ( Prof Paul Richardson and Prof Marivi Mateos )
13 Jun 2015

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia

Prof Susan Branford - Adelaide University Adelaide, Australia
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ( Prof Susan Branford - Adelaide University Adelaide, Australia )
13 Jun 2015

Transplantation combined with novel agents optimal treatment for multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA
Transplantation combined with novel agents optimal treatment for multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )
13 Jun 2015

Monoclonal antibodies and multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA
Monoclonal antibodies and multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )
13 Jun 2015

Factors influencing response to blinatumomab in relapsed/refractory ALL

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany
Factors influencing response to blinatumomab in relapsed/refractory ALL ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )
12 Jun 2015

DNMT3A R882 mutations promote chemoresistance and residual disease in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
12 Jun 2015

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

Prof Yilong Wu - President of the Chinese Society of Clinical Oncology
Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma ( Prof Yilong Wu - President of the Chinese Society of Clinical Oncology )
5 Jun 2015

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma

Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
5 Jun 2015

ASCO 2015: Latest developments in multiple myeloma

Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos
ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )
1 Jun 2015

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Dr James Larkin - Royal Marsden Hospital, London, UK
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
1 Jun 2015

Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs

Dr Richard Schilsky - University of Chicago, Chicago, USA
Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs ( Dr Richard Schilsky - University of Chicago, Chicago, USA )
1 Jun 2015

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA
Developments in clinical trials and health information technology that will improve targeted therapies for patients ( Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA )
1 Jun 2015